Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shanghai Henlius Biotech, Inc. Class H ( (HK:2696) ) has issued an announcement.
Shanghai Henlius Biotech, Inc. has been included in the MSCI Global Small Cap Indexes, effective after the market close on May 30, 2025. This inclusion is significant as the MSCI Indexes are widely referenced by international investment institutions, potentially enhancing the company’s visibility and attractiveness to investors.
More about Shanghai Henlius Biotech, Inc. Class H
Shanghai Henlius Biotech, Inc. is a biotechnology company based in China, focusing on the development and production of biologic drugs. The company is involved in the pharmaceutical industry, with a market focus on innovative therapies and biosimilars.
Average Trading Volume: 1,582,995
Technical Sentiment Signal: Buy
Current Market Cap: HK$19.89B
See more insights into 2696 stock on TipRanks’ Stock Analysis page.